propidium has been researched along with danthron in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, JH; Chung, JG; Hsia, TC; Huang, HY; Kuo, HM; Lee, TH; Ma, CY; Wu, PP; Yang, JS; Yang, MD | 1 |
1 other study(ies) available for propidium and danthron
| Article | Year |
|---|---|
Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways.
Topics: Annexin A5; Anthraquinones; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Membrane Permeability; DNA Damage; Fluorescein-5-isothiocyanate; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Propidium; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured | 2011 |